Gayathri Vijayakumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gayathri Vijayakumar has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alan Todd Blank
Department of Orthopedic Surgery, Section of Orthopedic Oncology, Rush University Medical Center, Chicago, Illinois
8 shared publications Alan T. Blank
Rush Univ, Dept Orthoped Surg, Div Orthoped Oncol, Med Ctr, Chicago, IL USA
3 shared publications- Ankica Braun
Department of Pathology, Rush University Medical Center, Chicago, Illinois
3 shared publications Conor M. Jones
Rush University Medical Center, Chicago, Illinois
3 shared publicationsIra Miller
Department of Pathology, Rush University Medical Center, Chicago, IL, USA
2 shared publicationsMatthew W. Colman
Rush University Medical Center, Chicago, Illinois
2 shared publications
Latest Publications
- 1 June 2025
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 21 (3) , 239-247
Opioid use in impending versus pathologic proximal femur fractures
Objectives: To investigate post-operative opioid use, functionality, and overall survival following internal fixation for pathologic or impending fractures at 3 and 6 months. Background: Pathologic and impending fractures commonly occur in the proximal femur, and patients may be prescribed opioids prior to surgery and often require opioids for post-operative pain relief. This study compared post-operative opiate usage and ambulatory functional status in patients with impending versus pathologic fractures in the proximal femur. Design: This was a retrospective case–control study of patients using opioids postoperatively who underwent internal fixation for a pathologic or impending fracture between 2016 and 2022. Preoperative and post-operative opioid usage as well as ambulation status and risk factors at 3 and 6 months associated with postoperative opioid use were recorded. Results: Twenty-four pathologic fractures and 23 impending fractures were included. Preoperative opioid daily morphine milligram equivalent was significantly higher in the pathologic fracture group, but there were no significant differences at 3 or 6 months. There was statistically significant post-operative improvement in ambulation status in the combined cohort and impending fracture cohort at 3 months and 6 months. Conclusions: Although patients did not experience a significant post-operative change in opioid use, patients with pathologic fractures notably required higher opioid dosages preoperatively, and there was overall improvement in function following fixation. Future studies should examine post-operative opioid use with careful consideration of concurrent pain management pain therapies and tumor characteristics.
- 1 June 2025
- Published by Weston Medical Publishing in Journal of Opioid Management
- Vol. 21 (3) , 239-247
Opioid use in impending versus pathologic proximal femur fractures
Objectives: To investigate post-operative opioid use, functionality, and overall survival following internal fixation for pathologic or impending fractures at 3 and 6 months. Background: Pathologic and impending fractures commonly occur in the proximal femur, and patients may be prescribed opioids prior to surgery and often require opioids for post-operative pain relief. This study compared post-operative opiate usage and ambulatory functional status in patients with impending versus pathologic fractures in the proximal femur. Design: This was a retrospective case–control study of patients using opioids postoperatively who underwent internal fixation for a pathologic or impending fracture between 2016 and 2022. Preoperative and post-operative opioid usage as well as ambulation status and risk factors at 3 and 6 months associated with postoperative opioid use were recorded. Results: Twenty-four pathologic fractures and 23 impending fractures were included. Preoperative opioid daily morphine milligram equivalent was significantly higher in the pathologic fracture group, but there were no significant differences at 3 or 6 months. There was statistically significant post-operative improvement in ambulation status in the combined cohort and impending fracture cohort at 3 months and 6 months. Conclusions: Although patients did not experience a significant post-operative change in opioid use, patients with pathologic fractures notably required higher opioid dosages preoperatively, and there was overall improvement in function following fixation. Future studies should examine post-operative opioid use with careful consideration of concurrent pain management pain therapies and tumor characteristics.
- 25 July 2024
- Published by Elsevier in European Journal of Radiology
- Vol. 178, 111634
Novel MRI scoring system to assess osseous malignancy in soft tissue sarcoma patients following radiotherapy
- 25 July 2024
- Published by Elsevier in European Journal of Radiology
- Vol. 178, 111634
Novel MRI scoring system to assess osseous malignancy in soft tissue sarcoma patients following radiotherapy
- 1 April 2024
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 14 (2)
Myoepithelial Carcinoma of Soft Tissue
Atients underwent surgical resection and are without evidence of local recurrence or metastatic disease at 1-year follow-up. Conclusion: Soft-tissue tumors presenting in the extremities warrant careful evaluation and timely histopathologic diagnosis. Myoepithelial carcinomas are rare, aggressive tumors with a propensity for local recurrence and metastasis. Treatment of these tumors should be discussed by a multidisciplinary tumor team....
- 1 April 2024
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 14 (2)
Myoepithelial Carcinoma of Soft Tissue
Atients underwent surgical resection and are without evidence of local recurrence or metastatic disease at 1-year follow-up. Conclusion: Soft-tissue tumors presenting in the extremities warrant careful evaluation and timely histopathologic diagnosis. Myoepithelial carcinomas are rare, aggressive tumors with a propensity for local recurrence and metastasis. Treatment of these tumors should be discussed by a multidisciplinary tumor team....
- Open Access
- 1 February 2024
- Published by SAGE Publications in Rare Tumors
- Vol. 16
Enormous myxoid/round cell liposarcoma: A case report
Myxoid/round cell liposarcomas (MRCLPS) are a rare soft tissue sarcoma. We report the largest sarcoma in our institutional history. We discuss the patient’s surgical management and treatment of the tumor and challenges given its dimensions. Several complications arose following primary resection that were managed by a multidisciplinary team. Although MRCLPS can vary in size, large MRCLPS must be treated cautiously given the potential for complications. Additionally, multidisciplinary treatment of MRCLPS is essential in diagnosing and treating these complex cases.
- 1 February 2024
- Published by SAGE Publications in Rare Tumors
- Vol. 16
Open AccessEnormous myxoid/round cell liposarcoma: A case report
Myxoid/round cell liposarcomas (MRCLPS) are a rare soft tissue sarcoma. We report the largest sarcoma in our institutional history. We discuss the patient’s surgical management and treatment of the tumor and challenges given its dimensions. Several complications arose following primary resection that were managed by a multidisciplinary team. Although MRCLPS can vary in size, large MRCLPS must be treated cautiously given the potential for complications. Additionally, multidisciplinary treatment of MRCLPS is essential in diagnosing and treating these complex cases.
- 31 January 2024
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 32 (7) , 1311-1318
An Unusual Case of Clear Cell Chondrosarcoma With Early Metastatic Recurrence
We present a case of a 58-year-old male who presented following 4 months of progressively worsening right upper extremity pain. Initial pathology demonstrated pleomorphic chondroblasts with increased mitotic activity indicating an intermediate grade (Grade 2) clear cell chondrosarcoma of the proximal humerus. Following surgical resection, the primary lesion demonstrated aggressive behavior and early metastasis to the cervical and thoracic spine. The patient unfortunately expired 30 months after initial presentation. Although clear cell chondrosarcoma has been historically regarded as low grade, we present a unique example of an aggressive clinical course of clear cell chondrosarcoma.
- 31 January 2024
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 32 (7) , 1311-1318
An Unusual Case of Clear Cell Chondrosarcoma With Early Metastatic Recurrence
We present a case of a 58-year-old male who presented following 4 months of progressively worsening right upper extremity pain. Initial pathology demonstrated pleomorphic chondroblasts with increased mitotic activity indicating an intermediate grade (Grade 2) clear cell chondrosarcoma of the proximal humerus. Following surgical resection, the primary lesion demonstrated aggressive behavior and early metastasis to the cervical and thoracic spine. The patient unfortunately expired 30 months after initial presentation. Although clear cell chondrosarcoma has been historically regarded as low grade, we present a unique example of an aggressive clinical course of clear cell chondrosarcoma.
- Open Access
- 24 January 2024
- Published by Hindawi Limited in Advances in Orthopedics
- Vol. 2024, 1-7
Evaluation of Absolute Neutrophil Count in the Perioperative Setting of Sarcoma Resection
Introduction. Limb salvage surgery (LSS) is the preferred surgical treatment for bone sarcomas. Preoperatively, many patients receive chemotherapy and may develop neutropenia. No study has evaluated the effect of a low preoperative absolute neutrophil count (ANC) on postoperative outcomes following LSS. Methods. This was a retrospective review of 114 patients who underwent LSS for bone sarcoma from 2010 to 2020. Preoperative lab values were analyzed by logistic regression to identify the risk of developing surgical complications within 30days, surgical site infection (SSI), and reoperation. Results. Three (2.6) patients experienced a surgical complication within 30days. Twelve (10.53) patients experienced postoperative SSI. Twenty-nine (25.4) required reoperation. Preoperative ANC was not a significant predictor of surgical complications within 30days, SSI, or reoperation. The only independent predictor of worse overall survival was the presence of a pathologic fracture at the time of surgery. Conclusion. This is the first study to evaluate preoperative ANC on postoperative outcomes following LSS. We report no significant differences in surgical complications within 30days, SSI, or reoperation with low preoperative ANC. Future studies with larger cohorts of neutropenic patients are needed to evaluate these outcomes, as our cohort had very few neutropenic patients due to selection bias.
- 24 January 2024
- Published by Hindawi Limited in Advances in Orthopedics
- Vol. 2024, 1-7
Open AccessEvaluation of Absolute Neutrophil Count in the Perioperative Setting of Sarcoma Resection
Introduction. Limb salvage surgery (LSS) is the preferred surgical treatment for bone sarcomas. Preoperatively, many patients receive chemotherapy and may develop neutropenia. No study has evaluated the effect of a low preoperative absolute neutrophil count (ANC) on postoperative outcomes following LSS. Methods. This was a retrospective review of 114 patients who underwent LSS for bone sarcoma from 2010 to 2020. Preoperative lab values were analyzed by logistic regression to identify the risk of developing surgical complications within 30days, surgical site infection (SSI), and reoperation. Results. Three (2.6) patients experienced a surgical complication within 30days. Twelve (10.53) patients experienced postoperative SSI. Twenty-nine (25.4) required reoperation. Preoperative ANC was not a significant predictor of surgical complications within 30days, SSI, or reoperation. The only independent predictor of worse overall survival was the presence of a pathologic fracture at the time of surgery. Conclusion. This is the first study to evaluate preoperative ANC on postoperative outcomes following LSS. We report no significant differences in surgical complications within 30days, SSI, or reoperation with low preoperative ANC. Future studies with larger cohorts of neutropenic patients are needed to evaluate these outcomes, as our cohort had very few neutropenic patients due to selection bias.
- Open Access
- 19 January 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 25, 101296
Does Perioperative Radiation Affect Implant Survivorship of Primary Total Hip Arthroplasty in the Setting of Metastatic Bone Disease?
- 19 January 2024
- Published by Elsevier in Arthroplasty Today
- Vol. 25, 101296
Open AccessDoes Perioperative Radiation Affect Implant Survivorship of Primary Total Hip Arthroplasty in the Setting of Metastatic Bone Disease?
- 4 August 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (3) , 418-424
Patient‐reported outcome tools in musculoskeletal oncology
Patient‐reported outcomes (PRO) are collected directly from the patient and have become increasingly utilized in the clinical setting and in clinical research. In musculoskeletal oncology patients, a number of patient‐reported outcomes measures (PROM) have been developed and investigated to evaluate functional outcomes and health‐related quality of life in these patients. With the growing evidence for PROM in musculoskeletal oncology patients, PROM should be considered for the clinical care of these patients.
- 4 August 2023
- Published by Wiley in Journal of Surgical Oncology
- Vol. 128 (3) , 418-424
Patient‐reported outcome tools in musculoskeletal oncology
Patient‐reported outcomes (PRO) are collected directly from the patient and have become increasingly utilized in the clinical setting and in clinical research. In musculoskeletal oncology patients, a number of patient‐reported outcomes measures (PROM) have been developed and investigated to evaluate functional outcomes and health‐related quality of life in these patients. With the growing evidence for PROM in musculoskeletal oncology patients, PROM should be considered for the clinical care of these patients.
- 1 July 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (3)
A Rare Location of Osteosarcoma in the Cuboid Bone
Case: In this case report, we describe a patient with left foot pain whose magnetic resonance imaging revealed a destructive tumor of the left cuboid bone. A biopsy of the tumor confirmed an osteoblastic osteosarcoma of the cuboid, and the patient was treated with chemotherapy followed by a below-the-knee amputation. Conclusion: There are only a handful of cases reporting osteosarcoma of the cuboid bone, and challenges remain in properly diagnosing the lesion to recommend the best course of treatment.
- 1 July 2023
- Published by Wolters Kluwer Health in JBJS Case Connector
- Vol. 13 (3)
A Rare Location of Osteosarcoma in the Cuboid Bone
Case: In this case report, we describe a patient with left foot pain whose magnetic resonance imaging revealed a destructive tumor of the left cuboid bone. A biopsy of the tumor confirmed an osteoblastic osteosarcoma of the cuboid, and the patient was treated with chemotherapy followed by a below-the-knee amputation. Conclusion: There are only a handful of cases reporting osteosarcoma of the cuboid bone, and challenges remain in properly diagnosing the lesion to recommend the best course of treatment.
- Open Access
- 20 April 2023
- Published by SAGE Publications in Rare Tumors
- Vol. 15
Epithelioid hemangioendothelioma of the distal lower extremity and the role of radiotherapy: A report of two cases
We report two cases of epithelioid hemangioendothelioma (EHE) in the distal lower extremity. Our first patient had unicentric EHE of the left os calcis initially treated with an intralesional procedure; however, later developed two recurrences which were managed with radiation therapy. Our second patient had multicentric EHE of the distal tibia and fibula managed with primary radiation therapy. Although EHE is typically treated with wide resection or an intralesional procedure, we present two cases of EHE in the distal lower extremity to discuss the therapeutic role of radiation therapy in the management of distal EHE.
- 20 April 2023
- Published by SAGE Publications in Rare Tumors
- Vol. 15
Open AccessEpithelioid hemangioendothelioma of the distal lower extremity and the role of radiotherapy: A report of two cases
We report two cases of epithelioid hemangioendothelioma (EHE) in the distal lower extremity. Our first patient had unicentric EHE of the left os calcis initially treated with an intralesional procedure; however, later developed two recurrences which were managed with radiation therapy. Our second patient had multicentric EHE of the distal tibia and fibula managed with primary radiation therapy. Although EHE is typically treated with wide resection or an intralesional procedure, we present two cases of EHE in the distal lower extremity to discuss the therapeutic role of radiation therapy in the management of distal EHE.